Steven Feldman
Site Head & Scientific Director, Laboratory for Cell & Gene Medicine Stanford GMP Facility
Seminars
Thursday 17th September 2026
Transitioning Between Viral & NonViral Platforms to Enhance CAR-T Safety & Durability
11:50 am
- Transitioning from a viral to non-viral platform for a cell therapy
- Overexpression of genes to enhance CAR-T function using a non-viral strategy for pediatric rare disease
Thursday 17th September 2026
Panel Discussion: Designing Early Manufacturing Processes with Long-term Strategic Alignment to Ensure Success in Phase 1 & Beyond
2:35 pm
- Establishing strategic manufacturing processes early to ensure phase one clarity, reduced rework and a scalable foundation for future growth
- Identifying optimal opportunities to optimize processes to improve manufacturing and trial outcomes
- Collaborating with flexible manufacturing partners to embed long term strategy from the beginning to support seamless scale up
